Über uns
Über uns
Führungsteam
Partnerschaften
Unsere Standorte
Technologie
Technologie
Produktion
Publikationen
Pipeline
Newsroom
News
Events
Downloads
Investor Relations
Überblick
Aktieninformation
Analysten-Coverage
Hauptversammlung
Finanzberichte
Corporate Governance
E-Mail Alert
Karriere
Werden Sie Teil der RNA people
Ausbildung
Aktuelle Stellenangebote
DE
Review Articles
New Vaccine Technologies to Combat Outbreak Situations
by Sovereign
mRNA: A novel Avenue to Antibody Therapy
by Sovereign
mRNA as novel technology for passive immunotherapy
by Sovereign
mRNA vaccine CV9103 and CV9104 for the treatment of prostate cancer
by Sovereign
A development, that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs
by Sovereign
A novel, disruptive vaccination technology, Self-adjuvanted RNActive® vaccines
by Sovereign
Developing mRNA-vaccine technologies
by Sovereign
mRNA: delivering an antitumor message
by Sovereign
Vaccination with messenger RNA
by Sovereign
RNA-based Therapies
by Sovereign
1
2
